CoChat

Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression

Geddes, JR, Freemantle, N, Mason, J, Eccles, MP, Boynton, J · 1999 · The Cochrane Database of Systematic Reviews
Cited by 107

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: To examine the relative efficacy of selective serotonin reuptake inhibitors (SSRIs) compared to other antidepressants. SEARCH STRATEGY: The search strategy included a search of (a) Electronic bibliographic databases (MEDLINE, EMBASE); (b) reference lists of related reviews (c) reference lists of all located studies (d) contact with the manufacturer and (e) the Cochrane Group register of controlled trials SELECTION CRITERIA: Randomised controlled trials comparing selective serotonin reuptake inhibitors with other kinds of antidepressants in the treatment of patients with depressive disorders. The outcome measures assessed included measures of the severity of depression. DATA COLLECTION AND ANALYSIS: Data were collected from each study the main outcome measurefrom each study. These included: mean Hamilton depression rating scale, mean Montgomery & Asberg depression rating scale, Clinical Global Impression rating scale. An analysis of standardised mean difference of these scales was performed using Review Manager 3. 1 software. The presence of heterogeneity of treatment effect was assessed MAIN RESULTS: Ninety-eight trials contributed data to the analysis of the relative efficacy of SSRIs and related drugs with comparator antidepressants (Figure 3 & Appendix 3). Analysis of efficacy was based upon 5044 patients treated with an SSRI or related drug, and 4510 treated with an alternative antidepressant. The standardised effect size for SSRIs and related drugs together versus alternative antidepressants using a fixed effects model was 0. 035 (95% CI -0.006 to 0.076; Q = 149.25, df = 97, p < 0.001). REVIEWER'S CONCLUSIONS: There are no clinically significant differences in effectiveness between selective serotonin reuptake inhibitors and tricyclic antidepressants. Treatment decisions need to be based on considerations of relative patient acceptability, toxicity and cost.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd001851This paper is marked retracted.

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 157

  1. Ahlfors, 1988, Clinical multicentre study of citalopram compared double-blindly with mianserin in depressed patients in Finland, Nordisk Psykiatrisk Tidsskrift, 42, 201, 10.3109/08039488809094957 · DOI
  2. Amin, 1984, Fluvoxamine; Antidepressant effects confirmed in a placebo controlled international study, Clinical Neuropharmacology, 7, 580
  3. Amore, 1989, Double-blind comparison of fluvoxamine and imipramine in depressed patients, Current Therapeutic Research; Clinical & Experimental, 46, 815
  4. Anonymous, 1986, Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study, Psychopharmacology, 90, 131
  5. Anonymous, 1988, A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness, International Clinical Psychopharmacology, 3, 75, 10.1097/00004850-198801000-00006 · DOI
  6. Anonymous, 1990, Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study, Journal of Affective Disorders, 18, 289, 10.1016/0165-0327(90)90081-I · DOI · Paper page
  7. Ansseau, 1994, Controlled comparison of nefazodone and amitriptyline in major depressive inpatients, Psychopharmacology, 115, 254, 10.1007/BF02244780 · doi:10.1007/bf02244780
  8. Arminen, 1992, Paroxetine and imipramine: A 12-week, double-blind multicentre study in hospitalized depressed patients, Nordisk Psykiatrisk Tidsskrift, 46, 27, 10.3109/08039489209101158 · DOI
  9. Barrelet, 1991, Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes, Schweizerische Rundschau fur Medizin Praxis, 80, 524
  10. Bascara, 1989, A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients, Acta Psychiatrica Scandinavica Supplementum, 350, 141, 10.1111/j.1600-0447.1989.tb07196.x · DOI
  11. Battegay, 1985, Double blind comparative study of paroxetine and amitryptline in depressed patients of a university psychiatric out-patient clinic (pilot study), Neuropsychobiology, 13, 31, 10.1159/000118159 · DOI
  12. Beasley, 1991, Fluoxetine versus trazodone: efficacy and activating-sedating effects, Journal of Clinical Psychiatry, 52, 294
  13. Beasley, 1993, Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial, Annals of Clinical Psychiatry, 5, 199, 10.3109/10401239309148983 · DOI · Paper page
  14. Beasley, 1993, Fluoxetine versus amitriptyline in the treatment of major depression: A multicenter trial, International Clinical Psychopharmacology, 8, 143, 10.1097/00004850-199300830-00002 · DOI · Paper page
  15. Benkert, 1996, A randomized double blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia, Journal of Psychiatric Research, 30, 441, 10.1016/S0022-3956(96)00029-5 · DOI
  16. Bersani, 1994, A double-blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes, Human Psychopharmacology, 9, 63, 10.1002/hup.470090108 · DOI
  17. Besancon, 1993, Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients, Encephale, 19, 341
  18. Bocksberger, 1993, Comparison of the efficacy of moclobemide and fluvoxamine in elderly patients with a severe depressive episode, European Psychiatry, 8, 319, 10.1017/S0924933800000705 · DOI
  19. Bouchard, 1987, Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients, Acta Psychiatrica Scandinavica, 76, 583, 10.1111/j.1600-0447.1987.tb02923.x · DOI · Paper page
  20. Bougerol, 1992, Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III). A French/Swiss double-blind trial, Psychopharmacology, 106, 102, 10.1007/BF02246249 · DOI
  21. Bowden, 1993, Fluoxetine and desiparmine in major depressive disorder, Journal of Clinical Psychopharmacology, 13, 305, 10.1097/00004714-199310000-00002 · DOI · Paper page
  22. Bramanti, 1988, An Italian multicenter experience with fluvoxamine, a new antidepressant drug, versus imipramine, Current Therapeutic Research, Clinical & Experimental, 43, 718
  23. Bremner, 1984, Fluoxetine in depressed patients: a comparison with imipramine, Journal of Clinical Psychiatry, 45, 414
  24. Cohn, 1984, A comparison of fluoxetine, imipramine and placebo in patients with depressive disorder, Journal of Clinical Psychiatry, 45, 414
  25. Cohn, 1985, A comparison of fluoxetine, imipramine and placebo in patients with major depressive disorders, Clinical Psychiatry, 46, 26
  26. Cohn, 1989, A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder, International Clinical Psychopharmacology, 4, 313, 10.1097/00004850-198910000-00006 · DOI · Paper page
  27. Cohn, 1990, Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients, Journal of Clinical Psychiatry, 51, 28
  28. Cohn, 1990, A placebo- and imipramine-controlled study of paroxetine, Psychopharmacology Bulletin, 26, 185
  29. Dalery, 1992, Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression, Encephale, 18, 257
  30. Jonghe, 1991, A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression, Pharmacopsychiatry, 24, 62, 10.1055/s-2007-1014440 · DOI · Paper page
  31. Jonghe, 1991, Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression, Pharmacopsychiatry, 24, 21, 10.1055/s-2007-1014428 · DOI
  32. Wilde, 1983, Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing, British Journal of Clinical Pharmacology, 15, 427, 10.1111/j.1365-2125.1983.tb02133.x · DOI
  33. Wilde, 1985, Citalopram versus mainserin: A controlled, double-blind trial in depressed patients, Acta Psychiatrica Scandinavica, 72, 89, 10.1111/j.1600-0447.1985.tb02576.x · DOI · Paper page
  34. Dick, 1983, A double blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine, British Journal of Clinical Pharmacology, 15, 419, 10.1111/j.1365-2125.1983.tb02132.x · DOI · Paper page
  35. Dominguez, 1985, A double blind controlled study of fluvoxamine and imipramine in depression, Journal of Clinical Psychiatry, 46, 84
  36. Dorman, 1992, Sleep and paroxetine: A comparison with mainserin in elderly depressed patients, International Clinical Psychopharmacology, 6, 53
  37. Dowling, 1990, Fluoxetine: A comparative study with dothiepin, Irish Joournal of Psychiatry, 11, 3
  38. Fabre, 1991, Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: A clinical study, Journal of Clinical Psychiatry, 52, 62
  39. Falk, 1989, Fluoxetine versus trazodone in depressed geriatric patients, Journal of Geriatric Psychiatry & Neurology, 2, 208, 10.1177/089198878900200407 · DOI · Paper page
  40. Feighner, 1985, Double blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder, Journal of Clinical Psychiatry, 46, 20
  41. Feighner, 1989, A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression, International Clinical Psychopharmacology, 4, 127, 10.1097/00004850-198904000-00004 · DOI · Paper page
  42. Feighner, 1989, A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression, Psychopharmacology Bulletin, 25, 219
  43. Feighner, 1993, A study comparing paroxetine placebo and imipramine in depressed patients, Journal of Affective Disorders, 28, 71, 10.1016/0165-0327(93)90035-I · DOI
  44. Ferreri, 1989, Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders, International Clinical Psychopharmacology, 4, 97
  45. Fontaine, 1994, A double-blind comparison of nefazodone, imipramine, and placebo in major depression, Journal of Clinical Psychiatry, 55, 234
  46. Fudge, 1990, A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients, Journal of Affective Disorders, 18, 275, 10.1016/0165-0327(90)90079-N · DOI
  47. Gattaz, 1995, Moclobemide versus fluoxetine in the treatment of inpatients with major depression, Journal of Clinical Psychopharmacology, 15, 35, 10.1097/00004714-199508001-00007 · DOI
  48. Geerts, 1994, Moclobemide versus fluoxetine for major depressive episodes, Clinical Neuropharmacology, 17, 50, 10.1097/00002826-199417001-00007 · DOI
  49. Geretsegger, 1995, Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients, Psychopharmacology, 119, 277, 10.1007/BF02246291 · DOI
  50. Ginestet, 1989, Fluoxetine in endogenous depression and melancholia versus clomipramine, International Clinical Psychopharmacology, 4, 37
  51. Gonella, 1990, Fluvoxamine and imipramine in the treatment of depressive patients: A double-blind controlled study, Current Medical Research & Opinion, 12, 177, 10.1185/03007999009111499 · DOI · Paper page
  52. Gravem, 1987, A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients, Acta Psychiatrica Scandinavica, 75, 478, 10.1111/j.1600-0447.1987.tb02821.x · DOI · Paper page
  53. Guelfi, 1983, A double blind placebo controlled clinical trial comparing fluvoxamine with imipramine, British Journal of Clinical Pharmacology, 15, 411, 10.1111/j.1365-2125.1983.tb02131.x · DOI
  54. Guillibert, 1989, A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients, Acta Psychiatrica Scandinavica Supplementum, 350, 132, 10.1111/j.1600-0447.1989.tb07192.x · DOI
  55. Harris, 1991, Fluvoxamine versus amitriptyline in depressed hospital out patients: A multicentre double blind comparative trial, British Journal of Clinical Research, 2, 89
  56. Hutchinson, 1992, Paroxetine in the treatment of elderly depressed patients in general practice: A double-blind comparison with amitriptyline, International Clinical Psychopharmacology, 6, 43, 10.1097/00004850-199206004-00009 · DOI · Paper page
  57. Itil, 1983, A double blind placebo-controlled study of fluvoxamine and imipramine in out patients with primary depression, British Journal of Clinical Pharmacology, 15, 433, 10.1111/j.1365-2125.1983.tb02134.x · DOI · Paper page
  58. Kasper, 1990, Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study, Pharmacopsychiatry, 23, 135, 10.1055/s-2007-1014496 · DOI · Paper page
  59. Keegan, 1991, A comparison of fluoxetine and amitriptyline in the treatment of major depression, International Clinical Psychopharmacology, 6, 117, 10.1097/00004850-199100620-00007 · DOI · Paper page
  60. Klok, 1981, Flovoxamine and clomipramine in depressed patients: A double blind clinical study, Acta Psychiatrica Scandinavica, 64, 1, 10.1111/j.1600-0447.1981.tb00756.x · DOI
  61. Kuha, 1991, The efficacy of fluoxetine versus maprotiline in depressed patients and by dose, NORD PSYKIATR TIDSSKR, 45, 109, 10.3109/08039489109103274 · DOI
  62. Kuhs, 1989, A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline, Acta Psychiatrica Scandinavica, Supplementum, 350, 145, 10.1111/j.1600-0447.1989.tb07198.x · DOI
  63. Pia, 1992, Double blind controlled study to evaluate the effectiveness and tolerability of fluoxetine versus mianserin in the treatment of depressive disorders among the elderly and their effects on cognitive behavioral parameters, New Trends in Experimental Psychiatry, 8, 139
  64. Laakmann, 1988, Fluoxetine vs amitriptyline in the treatment of depressed out-patients, British Journal of Psychiatry - Supplement, 3, 64, 10.1192/S0007125000297316 · DOI · Paper page
  65. Laakman, 1991, Selective re-uptake-hemmung und ihre bedeutung fur die depression, 10.1007/978-3-642-76137-9 · doi:10.1007/978-3-642-76137-9
  66. Lapierre, 1987, Treatment of major affective disorder with fluvoxamine, Journal of Clinical Psychiatry, 48, 65
  67. Laursen, 1985, Paroxetine in the treatment of depression a randomised comparison with amitriptyline, Acta Psychiatrica Scandinavica, 71, 249, 10.1111/j.1600-0447.1985.tb01281.x · DOI · Paper page
  68. Levine, 1989, A comparative trial of a new antidepressant, fluoxetine, International Clinical Psychopharmacology, 4, 41
  69. Lonnqvist, 1994, Antidepressant efficacy and quality of life in depression: A double-blind study with moclobemide and fluoxetine, Acta Psychiatrica Scandinavica, 89, 363, 10.1111/j.1600-0447.1994.tb01530.x · DOI · Paper page
  70. Lydiard, 1989, Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: Effects on depression, Psychopharmacology Bulletin, 25, 68
  71. Manna, 1989, Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders, International Clinical Psychopharmacology, 4, 81
  72. March, 1990, A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression, Journal of Clinical Psychiatry, 51, 200
  73. Mertens, 1988, Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin, Acta Psychiatrica Scandinavica, 77, 683, 10.1111/j.1600-0447.1988.tb05188.x · DOI · Paper page
  74. Moller, 1993, Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients, Pharmacopsychiatry, 26, 75, 10.1055/s-2007-1014346 · DOI · Paper page
  75. Moon, 1994, A double-blind comparison of sertrtraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice, Journal of Psychopharmacology, 8, 171, 10.1177/026988119400800306 · DOI
  76. Muijen, 1988, A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients, Acta Psychiatrica Scandinavica, 78, 384, 10.1111/j.1600-0447.1988.tb06353.x · DOI · Paper page
  77. Mullin, A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder, British Journal of Clinical Practice, 42, 51
  78. Nathan, 1990, The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine, Journal of Clinical Psychiatry, 51, 367
  79. Nielsen, 1991, Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements, Acta Psychiatrica Scandinavica, 84, 233, 10.1111/j.1600-0447.1991.tb03136.x · DOI
  80. Nielsen, 1993, A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder, Acta Psychiatrica Scandinavica, 87, 269, 10.1111/j.1600-0447.1993.tb03370.x · DOI
  81. Noguera, 1991, Fluoxetine vs. clomipramine in depressed patients: A controlled multicentre trial, Journal of Affective Disorders, 22, 119, 10.1016/0165-0327(91)90045-T · DOI
  82. Norton, 1984, A double blind comparison of fluvoxamine, imipramine and placebo in depressed patients, Journal of Affective Disorders, 7, 297, 10.1016/0165-0327(84)90051-X · DOI
  83. Ohrberg, 1992, Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice, Acta Psychiatrica Scandinavica, 86, 437, 10.1111/j.1600-0447.1992.tb03294.x · DOI
  84. Ottevanger, 1995, Fluvoxamine and clomipramine in depressed hospitalised patients: Results from a randomised, double-blind study, Encephale, 21, 317
  85. Pakesch, 1991, Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners, Wiener Klinische Wochenschrift, 103, 176
  86. Pelicier, 1993, Multicenter double-blind study comparing the efficacy and tolerance of paroxetine and clomipramine in reactive depression in the elderly patient, Encephale, 19, 257
  87. Peselow, 1989, The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo, Psychopharmacology Bulletin, 25, 267
  88. Peters, 1990, Therapy of depression in the psychiatrist's office - A double-blind multicenter study, Nervenheilkunde, 9, 28
  89. Phanjoo, 1991, Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people, Acta Psychiatrica Scandinavica, 83, 476, 10.1111/j.1600-0447.1991.tb05579.x · DOI · Paper page
  90. Poelinger, 1989, Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders, International Clinical Psychopharmacology, 4, 47
  91. Rahman, 1991, A double blind randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients, British Journal of Clinical Practice, 4, 255
  92. Ravindran, 1995, The impact of sertraline, desipramine, and placebo on psychomotor functioning in depression, Human Psychopharmacology, 10, 273, 10.1002/hup.470100404 · DOI · Paper page
  93. Ravindran, 1997, A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety, Journal of Clinical Psychiatry, 58, 112, 10.4088/JCP.v58n0305 · DOI · Paper page
  94. Reimherr, 1990, Antidepressant efficacy of sertraline: A double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression, Journal of Clinical Psychiatry, 51, 18
  95. Remick, 1989, A comparison between fluoxetine and doxepin in depressed patients, Current Therapeutic Research, Clinical & Experimental, 46, 842
  96. Remick, 1993, Comparison of fluoxetine and desipramine in depressed outpatients, Current Therapeutic Research, Clinical & Experimental, 53, 457, 10.1016/S0011-393X(05)80653-8 · DOI
  97. Remick, 1994, Comparison of fluvoxamine and amitriptyline in depressed outpatients, Current Therapeutic Research, Clinical & Experimental, 55, 243, 10.1016/S0011-393X(05)80168-7 · DOI
  98. Reynaert, 1995, Moclobemide versus fluoxetine for a major depressive episode, Psychopharmacology, 118, 183, 10.1007/BF02245838 · DOI
  99. Rickels, 1994, Nefazodone and imipramine in major depression: A placebo-controlled trial, British Journal of Psychiatry, 164, 802, 10.1192/bjp.164.6.802 · DOI · Paper page
  100. Robertson, 1994, A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness, Journal of Psychopharmacology, 8, 98, 10.1177/026988119400800205 · DOI
  101. Ropert, 1989, Fluoxetine versus clomipramine in major depressive disorders, International Clinical Psychopharmacology, 4, 89
  102. Roth, 1990, A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 14, 929, 10.1016/0278-5846(90)90078-U · DOI
  103. Schweizer, 1994, Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients, Journal of Clinical Psychiatry, 55, 104
  104. Shaw, 1986, A comparison of the antidepressant action of citalopram and amitriptyline, British Journal of Psychiatry, 149, 515, 10.1192/bjp.149.4.515 · DOI · Paper page
  105. Shrivastava, 1994, Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression, Journal of Clinical Psychopharmacology, 14, 322, 10.1097/00004714-199410000-00006 · DOI · Paper page
  106. Stark, 1985, A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in out-patients with major depressive disorder, Journal of Clinical Psychiatry, 46, 53
  107. Stott, 1993, Depression and associated anxiety in primary care: A double-blind comparison of paroxetine and amitriptyline, European Neuropsychopharmacology, 3, 324, 10.1016/0924-977X(93)90100-Z · DOI
  108. Stratta, 1991, A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression, International Clinical Psychopharmacology, 6, 193, 10.1097/00004850-199100630-00007 · DOI
  109. Stuppaeck, 1994, A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients, Journal of Clinical Psychopharmacology, 14, 241, 10.1097/00004714-199408000-00003 · DOI · Paper page
  110. Tapani, 1989, A double blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders, International Journal of Psychopharmacology, 4, 51
  111. Thompson, 1991, Sertraline in a primay care setting, 863
  112. Timmerman, 1987, A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients, International Clinical Psychopharmacology, 2, 239, 10.1097/00004850-198707000-00006 · DOI
  113. Upward, 1988, Comparative effects of fluoxetine and amitriptyline on cardiac function, British Journal of Clinical Pharmacology, 26, 399, 10.1111/j.1365-2125.1988.tb03397.x · DOI · Paper page
  114. Williams, 1993, A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders, International Clinical Psychopharmacology, 7, 155, 10.1097/00004850-199300730-00006 · DOI · Paper page
  115. Young, 1987, A controlled comparison of fluoxetine and amitriptyline in depressed out-patients, British Journal of Psychiatry, 151, 337, 10.1192/bjp.151.3.337 · DOI · Paper page
  116. Altamura, 1989, Fluoxetine compared with amitriptyline in elderly depression: A controlled clinical trial, International Journal of Clinical Pharmacology Research, 9, 391
  117. Bressa, 1989, A double-blind study of fluoxetine and imipramine in major depression, International Clinical Psychopharmacology, 4, 69
  118. Chouinard, 1985, A double-blind controlled clinical trial of fluoxetine and amitryptiline in the treatment of outpatients with major depressive disorder, Journal of Clinical Psychiatry, 46, 32
  119. Wilde, 1982, Fluvoxamine and chlorimipramine in endogenous depression, Journal of Affective Disorders, 4, 9, 10.1016/0165-0327(82)90009-X · DOI
  120. Debus, 1988, Fluoxetine versus trazodone in the treatment of outpatients with major depression, Journal of Clinical Psychiatry, 4, 422
  121. Doogan, 1994, A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice, International Clinical Psychopharmacology, 9, 95, 10.1097/00004850-199400920-00005 · DOI · Paper page
  122. Dunbar, 1991, A comparison of paroxetine, imipramine and placebo in depressed out-patients, British Journal of Psychiatry, 159, 394, 10.1192/bjp.159.3.394 · DOI · Paper page
  123. Entsuah, 1994, Cumulative mean change procedure: Application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 1 8, 695, 10.1016/0278-5846(94)90077-9 · DOI
  124. Fairweather, 1993, A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients, Human Psychopharmacology, 8, 41, 10.1002/hup.470080108 · DOI · Paper page
  125. Feighner, 1985, A comparative trial of fluoxetine and amitryptline in patients with major depressive disorder, Journal of Clinical Psychiatry, 46, 369
  126. Feighner, 1989, A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression, International Clinical Psychopharmacology, 4, 239, 10.1097/00004850-198907000-00006 · DOI · Paper page
  127. Feighner, 1989, Paroxetine in the treatment of depression: a comparison with imipramine and placebo, Acta Psychiatrica Scandinavica, Supplementum, 350, 125, 10.1111/j.1600-0447.1989.tb07190.x · DOI · Paper page
  128. Fontaine, 1991, The efficacy and safetly of sertraline versus imipramine in outpatients with major depression: A six month double bolind parallel multicentre study, European Neuropsychopharmacology, 1, 75, 10.1016/0924-977X(91)90658-H · DOI
  129. Gagiano, 1989, The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients, Acta Ps ychiatrica Scandinavica, Supplementum, 350, 130, 10.1111/j.1600-0447.1989.tb07191.x · DOI
  130. Guy, 1984, Double blind clinical trial fo fluvoxamine and imipramine in patients with primary depression, Psychopharmacology Bulletin, 20, 73
  131. Hewer, 1994, Effects of fluvoxamine and maprotiline on ECG parameters, Nervenheilkunde, 13, 375
  132. Loeb, 1989, Fluoxetine versus imipramine, International Clinical Psychopharmacology, 4, 75
  133. Masco, 1985, Double-blind comparison of fluoxetine and amitryptyline in the treatment of major depressive illness, Advances in Therapy, 2, 275
  134. Moon, 1989, Fluvoxamine versus mianserin: Psychomotor performance in depressed patients, Journal of Psychopharmacology, 3, 93
  135. Perry, 1989, A comparative trial of fluoxetine versus trazodone in outpatients with major depression, Journal of Clinical Psychiatry, 50, 290
  136. Taneri, 1989, Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder, International Clinical Psychopharmacology, 4, 57
  137. Moffaert, 1994, A double-blind comparison of nefazodone and imipramine in the treatment of depressed patients, New Trends in Experimental & Clinical Psychiatry, 10, 85
  138. Anderson, 1995, Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: A meta analysis, BMJ, 310, 1433, 10.1136/bmj.310.6992.1433 · DOI · Paper page
  139. Anonymous, 1993, Selective serotonin reuptake inhibitors for depression?, Drug and Therapeutics Bulletin, 31, 57, 10.1136/dtb.31.15.57 · doi:10.1136/dtb.31.15.57
  140. Blacker, 1988, The prevalence and treatment of depression in general practice, Psychopharmacology, 95, 14
  141. DerSimonian, 1986, Meta analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  142. Eccles, 1999, North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. North of England Anti-depressant Guideline Development Group, Family Practice, 16, 103, 10.1093/fampra/16.2.103 · DOI · Paper page
  143. 1993, The treatment of depression in primary care
  144. Freemantle, 1994, Selective serotonin reuptake inhibitor prescribing as a strategy for the prevention of suicide, BMJ, 309, 249, 10.1136/bmj.309.6949.249 · DOI
  145. Goldberg, 1992, Common mental disorders
  146. Harrison, 1994, New or old antidepressant? New is better, BMJ, 309, 1280, 10.1136/bmj.309.6964.1280 · doi:10.1136/bmj.309.6964.1280
  147. Hedges, 1985, Statistical methods for meta analysis
  148. Hotopf, 1996, Are SSRIs a cost effective alternative to tricyclics?, British Journal of Psychiatry, 168, 404, 10.1192/bjp.168.4.404 · DOI · Paper page
  149. Jonsson, 1994, What price depression? The cost of depression and the cost effectiveness of pharmacological treatment, British Journal of Psychiatry, 164, 665, 10.1192/bjp.164.5.665 · DOI · Paper page
  150. Montgomery, 1994, Selective serotonin reuptake inhibitors: Meta analysis of discontinuation rates, International Clinical Psychopharmacology, 9, 47, 10.1097/00004850-199400910-00008 · DOI · Paper page
  151. Montgomery, 1995, Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis, International Clinical Psychopharmacology, 5, 33, 10.1097/00004850-199501004-00005 · DOI · Paper page
  152. Murray, Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease study, 1997, 349, 1347
  153. Murray, 1997, Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study, Lancet, 349, 1498, 10.1016/S0140-6736(96)07492-2 · DOI · Paper page
  154. Owens, 1994, Benefits of new drugs are exaggerated, BMJ, 309, 1281, 10.1136/bmj.309.6964.1281 · DOI
  155. Pocock, 1983, Clinical trials: A practical approach
  156. Schulz, 1995, Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trial, JAMA, 273, 408, 10.1001/jama.1995.03520290060030 · DOI
  157. Whitehead, 1991, A general parametric approach to the meta analysis of randomized clinical trials, Statistics in Medicine, 10, 1665, 10.1002/sim.4780101105 · DOI · Paper page

Cited by

See all 107

Metadata

Authors
Geddes, Jr., Freemantle, N., Mason, J., Eccles, M., & Boynton, J.
Venue
The Cochrane Database of Systematic Reviews
Published
1999-10-25
Issue
2
Pages
CD001851-CD001851
OpenAlex
W19903215
Cited by
107
References
12
Type
reference entry
Language
en
Status
Retracted
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.